CING
Cingulate Inc
NASDAQ: CING · HEALTHCARE · BIOTECHNOLOGY
$4.96
-6.35% today
Updated 2026-06-05
Market cap
$61.26M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.33
Dividend yield
—
52W range
$3 – $12
Volume
0.6M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.5
Quality
C+3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-16.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$24.92
+402.42%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.39x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -16.41 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-6.97M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-17.85M | $-23.53M | $-16.56M | $-22.45M | $-9.31M |
| EPS | — | — | — | — | $-4.33 |
| Free cash flow | $-16.04M | $-15.26M | $-18.66M | $-17.41M | $-6.97M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Cingulate Inc trades at $4.96. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -16.41, it sits in the distress.
Frequently asked questions
What is Cingulate Inc's stock price?
Cingulate Inc (CING) trades at $4.96.
Is Cingulate Inc overvalued?
Cingulate Inc carries a Smart Value Score of 21/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Cingulate Inc (CING)?
The 12-month analyst consensus target is $24.92, about 402.4% above the current $4.96. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Cingulate Inc's Altman Z-Score is -16.41, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-146.91%
Beta-0.85
50D MA$5.25
200D MA$4.91
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—